About Firm News
In the News
Lisa Dwyer comments on the inherent risk of AI usage in clinical trial development
May 21, 2024
| InsideHealthPolicy

Go to the article

Related Capabilities
Artificial Intelligence (AI) & Machine Learning FDA & Life Sciences
Explore King & Spalding
a blue and green background
Capabilities
Artificial Intelligence (AI) & Machine Learning
Learn More
a blue and green background
Capabilities
FDA & Life Sciences
Learn More